INFLUENCE OF STAPHYLOCOCCUS VACCINE ON FUNCTIONAL ACTIVITY OF ANTIGEN-PRESENTING CELLS


Cite item

Full Text

Abstract

Aim. Study the influence of staphylococcus vaccine on functional activity of antigen-presenting cells. Materials and methods. Mice intraperitoneally received 500 ^g of «Staphylovac» vaccine. Phagocytic activity of peritoneal macrophages against Staphylococcus aureus 1991 was determined in animals at various time intervals. Phagocytic index (PI) and phagocytic number (PN) in smears made at 30 and 60 minutes of incubation were calculated. Dendritic cells (DC) were obtained from bone marrow precursors during cultivation with 20 ng/ml GM-CSF and 20 ng/ml IL-4 (BioSource International Inc., Belgium). At day 6 of incubation staphylococcus vaccine (50 ^g/ml) was added to immature cells for induction of DC maturation. DC phenotype evaluation was carried out by flow cytometry using monoclonal antibodies against cell antigens (Beckman Culter, USA). Results. PI at 30 and 60 minutes of incubation increased by 0.12 - 1.4 times and 1.11 - 1.52 times, respectively, compared with control. PN at 30 minutes of incubation of cells with microbial suspension increased from 8.6 to 11.4% against 5.9% in control, at 60 minutes of incubation - from 7.7 to 8.1% against 5.1% in control. In DC culture during their incubation with the vaccine, content of cells with expression of intercellular adhesion marker CD38, antigen presenting marker MHCII and DC terminal differentiation marker CD83 increased. Expression of CD34 and CD14 was also noted, that may give evidence on partial direction of cell differentiation to macrophages. Conclusion. «Staphylovac» vaccine during intraperitoneal administration to mice had activating influence on functional activity of antigen-presenting cells and peritoneal macrophages.

About the authors

E. A Akhmatov

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

E. V Sorokina

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

O. M Ignatova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

L. S Cherkasova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

References

  1. Волкова Е.Н., Бутов Ю.С., Морозов С.Г. К проблеме иммунопатогенеза гнойничковых заболеваний кожи. Вестн. дерматол. венерол. 2004, 1: 20-22.
  2. Дехнич А.В., Никулин А.А., Рябкова Е.Л., Кречикова О.И., Сухорукова М.В., Козлов Р.С. Эпидемиология резистентности штаммов S. aureus, выделенных от пациентов в ОРИТ российских стационаров: результаты многоцентрового исследования. Клин. микробиол. антимикроб. химиотер. 2008, 10 (4): 333-344.
  3. Егорова Н.Б., Ефремова В.Н., Курбатова Е.А., Грубер И.М. Данные экспериментального и клинико-иммунологического изучения бесклеточной стафилококковой вакцины «Стафиловак». Журн. микробиол. 2008, 6: 102-108.
  4. Ефремова В.Н., Егорова Н.Б., Масюкова С.А. Бесклеточная антистафилококковая вакцина для лечения хронической стафилококковой инфекции. Патент РФ № 2122862 от 10.12.1998.
  5. Масюкова С.А., Ефремова В.Н., Федоров С.М. Вакцинотерапия больных хронической пиодермией сухой бесклеточной стафилококковой вакциной. Вестн. дерматол. венерол. 1993, 4: 64-68.
  6. Пащенков М.В., Пинегин Б.В. Физиология клеток врожденной иммунной системы: Дендритные клетки. Иммунол. 2006, 6: 368-377.
  7. Семенов Б.Ф., Ахматова Н.К., Киселевский М.В. и др. Клеточные и молекулярные события при введении поликомпонентной бактериальной вакцины и заражении S. typhimurium. Молекул. мед. 2005, 4: 48-54.
  8. Сорокина Е.В. Бактериальные вакцины в терапии хронической пиодермии. Автореф. дис. канд.мед.наук. М., 2006.
  9. Boehm T., Hess I., Swann J.B. Evolution of lymphoid tissues. Trends Immunol. 2012, 33 (6): 315-321.
  10. Carreno B.M., Becker-Hapak M., Huang A. et al. IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J.Clin. Invest. 2013, 123 (8): 3383-3394.
  11. Dannull J., Haley N.R., Archer G. et al. M. Melanoma immunotherapy using mature DCs expressing the constitutive proteasome. J. Clin. Invest. 2013, 123 (7): 3135-3145.
  12. Iwatsuki K., Y&masaki O., Morizane S., Oono T. Staphylococcal cutaneous infections: invasion, evasion and aggression. J. Dermatol. Sci. 2006, 42 (3): 203-214.
  13. Lee S.W., Park H.J., Kim N., Hong S. Natural killer dendritic cells enhance immune responses elicited by a-galactosylceramide-stimulated natural killer T cells. Biomed. Res. Int. 2013, 2013: 460706.
  14. Li M., Jiang Y, Xu C. et al. Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant. Int. J. Nanomedicine. 2013, 8: 1843-1854.
  15. Mitosek-Szewczyk K., Tabarkiewicz J., Wilczynska B. et al. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis. J. Neurol. Sci. 2013, 332 (1-2): 35-40.
  16. Nieminen J.K., Niemi M., Sipponen T. et al. Dendritic cells from Crohn’s disease patients show aberrant STAT1 and STAT3 signaling. PLoS One. 2013, 7; 8 (8): e70738.
  17. Tan C., Dannull J., Nair S.K. et al. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination. J. Surg. Res. 2013, pii: S0022-4804(13)00671- 9.
  18. Thammavongsa V., Missiakas D.M., Schneewind O. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science. 2013, 342 (6160): 863-866.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Akhmatov E.A., Sorokina E.V., Ignatova O.M., Cherkasova L.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies